What You Should Know:
–TailorMed, a leading innovator in healthcare technology, announced a $40 million financing round combining equity and debt. This investment positions the company to advance its bold vision of transforming medication access, adherence, and affordability across the United States.
– Windham Capital Partners led the round, alongside Citi Impact Fund, Samsung Next, and BrightEdge, and the investment arms of some of the nation’s top health systems: Providence Ventures, OSF Healthcare, Inception Health, Ballad Ventures, UH Ventures, and UnityPoint Health Ventures. TailorMed also benefited from the continued support of its early investors: Sanara Ventures, Triventures, Accelmed, Almeda Ventures, and Bridges. The debt facility was led by Poalim-tech, part of Israel’s leading bank, Bank HaPoalim.
TailorMed: Revolutionizing Healthcare Affordability and Access
TailorMed is reshaping the healthcare landscape with its comprehensive, end-to-end platform designed to eliminate barriers to medication affordability, access, and adherence. By fostering collaboration among patients, providers, pharmacies, life sciences, and payers, TailorMed is building a new category in healthcare—one that ensures timely and equitable access to treatment for every patient, regardless of medical condition or financial circumstance.
Addressing Critical Challenges in Healthcare
Healthcare affordability in the U.S. remains a pressing issue:
- Only 55% of adults can afford necessary care, often resulting in delayed or skipped treatments that worsen health outcomes.
- Over 100 million Americans face medical debt, which drives 65% of all bankruptcies.
TailorMed has created the nation’s largest affordability network, connecting key stakeholders to address these challenges. By focusing on patients’ needs for affordable medications—whether at the doctor’s office, pharmacy, infusion center, or at home—TailorMed aims to unlock the full spectrum of medication access, ensuring continuity of care throughout every stage of the patient journey.
Building an End-to-End Solution
TailorMed’s enterprise platform manages the full lifecycle of patient support programs, reducing the cost of care and driving better outcomes:
- Cost Barriers: Tackles financial hurdles through its affordability network, linking patients with financial assistance programs and resources.
- Access Barriers: Streamlines prescription fulfillment and medication delivery across care settings.
- Data Integration: Facilitates seamless collaboration among providers, pharmacies, and life science companies by creating a connected ecosystem for data and resource sharing.
This holistic approach allows TailorMed to expand its impact beyond affordability, addressing broader challenges across the medication continuum.
Momentum and Vision for the Future
Over the past six years, TailorMed has partnered with leading health systems, pharmacies, and life science companies to drive medication affordability on a massive scale. With its robust network and strong industry relationships, the company is poised to tackle new challenges in healthcare access.
Srulik Dvorsky, CEO and Co-Founder of TailorMed, emphasized the company’s mission: “We’ve made significant strides in empowering our network to make healthcare more affordable, but our work is far from over. This new funding will propel us forward, allowing us to break down additional barriers and create a healthcare system where affordability is the norm. With the support of Windham Capital Partners and other visionary investors, we’re committed to transforming access to care for millions.”
A Future of Equitable Healthcare
TailorMed’s innovative solutions and expanding network are setting a new standard in healthcare—one where every patient can access the medications they need without financial or logistical delays. As the company evolves its end-to-end platform, it continues to drive its vision of equitable, affordable healthcare for all.
